Premium
P3‐062: EFFECT OF REPEATED ADMINISTRATION OF E2027, A NOVEL PHOSPHODIESTERASE‐9 INHIBITOR, ON CYCLIC GMP LEVELS IN RAT CEREBROSPINAL FLUID
Author(s) -
Ando Mai,
Ishikawa Yukio,
Horie Kanta,
Mochizuki Toshiki,
Yamamoto Masae,
Watanabe Naoto,
Nakatani Yosuke,
Kotani Sadaharu,
Fukushima Tatsuto
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1418
Subject(s) - cyclic guanosine monophosphate , phosphodiesterase , cerebrospinal fluid , medicine , phosphodiesterase inhibitor , endocrinology , pharmacology , chemistry , enzyme , biochemistry , nitric oxide